127 related articles for article (PubMed ID: 20412041)
41. QSAR of matrix metalloproteinase inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzylglycine hydroxamates using LFER model.
Roy K; Pal DK; De AU; Sengupta C
Drug Des Discov; 2001; 17(4):315-23. PubMed ID: 11765134
[TBL] [Abstract][Full Text] [Related]
42. Lipoxygenase inhibitors derived from marine macroalgae.
Kurihara H; Kagawa Y; Konno R; Kim SM; Takahashi K
Bioorg Med Chem Lett; 2014 Mar; 24(5):1383-5. PubMed ID: 24495846
[TBL] [Abstract][Full Text] [Related]
43. In vitro studies of some 2,4-disubstituted thiazolyl-aminoketones with anti-inflammatory activity. Correlation with lipophilicity and structural characteristics.
Geronikaki AA; Hadjipavlou-Litina DJ
Arzneimittelforschung; 1996 Dec; 46(12):1134-7. PubMed ID: 9006787
[TBL] [Abstract][Full Text] [Related]
44. Trioxsalen derivatives with lipoxygenase inhibitory activity.
Hadjipavlou-Litina D; E Bariamis S; Militsopoulou M; Athanassopoulos CM; Papaioannou D
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1351-6. PubMed ID: 19912068
[TBL] [Abstract][Full Text] [Related]
45. Development of 3D-QSAR models for 5-lipoxygenase antagonists: chalcones.
Arockia Babu M; Shakya N; Prathipati P; Kaskhedikar SG; Saxena AK
Bioorg Med Chem; 2002 Dec; 10(12):4035-41. PubMed ID: 12413856
[TBL] [Abstract][Full Text] [Related]
46. Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase.
Tehrani MB; Emami S; Asadi M; Saeedi M; Mirzahekmati M; Ebrahimi SM; Mahdavi M; Nadri H; Moradi A; Moghadam FH; Farzipour S; Vosooghi M; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Nov; 87():759-64. PubMed ID: 25310714
[TBL] [Abstract][Full Text] [Related]
47. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.
Bruno F; Spaziano G; Liparulo A; Roviezzo F; Nabavi SM; Sureda A; Filosa R; D'Agostino B
Eur J Med Chem; 2018 Jun; 153():65-72. PubMed ID: 29133059
[TBL] [Abstract][Full Text] [Related]
48. The novel ketoprofen amides--synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents.
Rajić Z; Hadjipavlou-Litina D; Pontiki E; Kralj M; Suman L; Zorc B
Chem Biol Drug Des; 2010 Jun; 75(6):641-52. PubMed ID: 20337784
[TBL] [Abstract][Full Text] [Related]
49. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
[TBL] [Abstract][Full Text] [Related]
50. Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA.
Caballero J; Fernández M; Coll D
Chem Biol Drug Des; 2010 Dec; 76(6):511-7. PubMed ID: 21040497
[TBL] [Abstract][Full Text] [Related]
51. Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.
Lill AP; Rödl CB; Steinhilber D; Stark H; Hofmann B
Eur J Med Chem; 2015 Jan; 89():503-23. PubMed ID: 25462262
[TBL] [Abstract][Full Text] [Related]
52. Aminothiazole derivatives with antidegenerative activity on cartilage.
Panico AM; Geronikaki A; Mgonzo R; Cardile V; Gentile B; Doytchinova I
Bioorg Med Chem; 2003 Jul; 11(13):2983-9. PubMed ID: 12788367
[TBL] [Abstract][Full Text] [Related]
53. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
Gupta A; Kumar V; Aparoy P
Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
56. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
Greco MN; Hageman WE; Powell ET; Tighe JJ; Persico FJ
J Med Chem; 1992 Aug; 35(17):3180-3. PubMed ID: 1324317
[TBL] [Abstract][Full Text] [Related]
57. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
[TBL] [Abstract][Full Text] [Related]
58. 2-Arylbenzo[b]furan derivatives as potent human lipoxygenase inhibitors.
Lang L; Dong N; Wu D; Yao X; Lu W; Zhang C; Ouyang P; Zhu J; Tang Y; Wang W; Li J; Huang J
J Enzyme Inhib Med Chem; 2016; 31(sup4):98-105. PubMed ID: 27590167
[TBL] [Abstract][Full Text] [Related]
59. Computer modeling in predicting the bioactivity of human 5-lipoxygenase inhibitors.
Zhang M; Xia Z; Yan A
Mol Divers; 2017 Feb; 21(1):235-246. PubMed ID: 27904990
[TBL] [Abstract][Full Text] [Related]
60. Quantitative structure-retention relationship of new N-substituted 2-alkylidene-4-oxothiazolidines.
Dabić D; Natić M; Džambaski Z; Marković R; Milojković-Opsenica D; Tešić Ž
J Sep Sci; 2011 Sep; 34(18):2397-404. PubMed ID: 21735548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
